Assignee
ACCURAGEN HOLDINGS LTD
KY·16 granted patents·14 pending applications·76 citations·filing 2014–2025
Top patents by PatentIndex Score
30 records- 0198US11643683B2Compositions and methods for detecting rare sequence variantsACCURAGEN HOLDINGS LTD·Filed 2020·Granted May 9, 2023·6 cites·19 claims
- 0296US11578359B2Methods and compositions for enrichment of amplification productsACCURAGEN HOLDINGS LTD·Filed 2020·Granted Feb 14, 2023·5 cites·22 claims
- 0396US10155980B2Compositions and methods for detecting rare sequence variantsACCURAGEN HOLDINGS LTD·Filed 2017·Granted Dec 18, 2018·20 cites·30 claims
- 0494US10724088B2Compositions and methods for detecting rare sequence variantsACCURAGEN HOLDINGS LTD·Filed 2018·Granted Jul 28, 2020·9 cites·23 claims
- 0592US11597973B2Compositions and methods for detecting rare sequence variantsACCURAGEN HOLDINGS LTD·Filed 2020·Granted Mar 7, 2023·6 cites·28 claims
- 0692US10767222B2Compositions and methods for detecting rare sequence variantsACCURAGEN HOLDINGS LTD·Filed 2014·Granted Sep 8, 2020·10 cites·26 claims
- 0792US10752942B2Methods and compositions for enrichment of amplification productsACCURAGEN HOLDINGS LTD·Filed 2018·Granted Aug 25, 2020·10 cites·48 claims
- 0888US11203782B2Compositions and methods comprising asymmetric barcodingACCURAGEN HOLDINGS LTD·Filed 2019·Granted Dec 21, 2021·3 cites·20 claims
- 0987US11427866B2Method of improved sequencing by strand identificationACCURAGEN HOLDINGS LTD·Filed 2017·Granted Aug 30, 2022·4 cites·16 claims
- 1085US11286519B2Methods and compositions for enrichment of amplification productsACCURAGEN HOLDINGS LTD·Filed 2019·Granted Mar 29, 2022·3 cites·23 claims
- 1182US12234512B2Compositions and methods for detecting rare sequence variantsACCURAGEN HOLDINGS LTD·Filed 2023·Granted Feb 25, 2025·0 cites·15 claims
- 1281US2023357836A1Compositions and methods for detecting rare sequence variantsACCURAGEN HOLDINGS LTD·Filed 2023·Application pending·0 cites
- 1376US2023287485A1Methods and compositions for enrichment of amplification productsACCURAGEN HOLDINGS LTD·Filed 2023·Application pending·0 cites
- 1471US2025290136A1Compositions and methods for detecting rare sequence variantsACCURAGEN HOLDINGS LTD·Filed 2025·Application pending·0 cites
- 1570US2025154602A1Compositions and methods for detecting rare sequence variantsACCURAGEN HOLDINGS LTD·Filed 2024·Application pending·0 cites
- 1667US12043867B2Compositions and methods comprising asymmetric barcodingACCURAGEN HOLDINGS LTD·Filed 2021·Granted Jul 23, 2024·0 cites·15 claims
- 1765US2024117443A1Gene expression and cell-free dna methods and systems for disease detectionACCURAGEN HOLDINGS LTD·Filed 2023·Application pending·0 cites
- 1864US2023265486A1Methods for selective cell-free nucleic acid analysisACCURAGEN HOLDINGS LTD·Filed 2023·Application pending·0 cites
- 1962US12247252B2Method of improved sequencing by strand identificationACCURAGEN HOLDINGS LTD·Filed 2022·Granted Mar 11, 2025·0 cites·8 claims
- 2062US2023348986A1Methods and systems for sample normalizationACCURAGEN HOLDINGS LTD·Filed 2023·Application pending·0 cites
- 2159US2023167508A1Cell-free dna size detectionACCURAGEN HOLDINGS LTD·Filed 2022·Application pending·0 cites
- 2258US2022325361A1Methods and systems for disease detectionACCURAGEN HOLDINGS LTD·Filed 2022·Application pending·0 cites
- 2357US2022112540A1Methods and systems for disease detectionACCURAGEN HOLDINGS LTD·Filed 2021·Application pending·0 cites
- 2455US12049665B2Methods and compositions for forming ligation productsACCURAGEN HOLDINGS LTD·Filed 2019·Granted Jul 30, 2024·0 cites·15 claims
- 2555US2025327135A1Tumor nucleic acid identification methodsACCURAGEN HOLDINGS LTD·Filed 2025·Application pending·0 cites
- 2655US2022033916A1Methods and compositions for early cancer detectionACCURAGEN HOLDINGS LTD·Filed 2021·Application pending·0 cites
- 2755US2021301328A1Compositions and methods for digital polymerase chain reactionACCURAGEN HOLDINGS LTD·Filed 2020·Application pending·0 cites
- 2853US11859246B2Methods and compositions for enrichment of amplification productsACCURAGEN HOLDINGS LTD·Filed 2019·Granted Jan 2, 2024·0 cites·28 claims
- 2945US12163184B2Methods and compositions for forming ligation productsACCURAGEN HOLDINGS LTD·Filed 2016·Granted Dec 10, 2024·0 cites·10 claims
- 3045US2019323073A1Cell-free nucleic acid standards and uses thereofACCURAGEN HOLDINGS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ACCURAGEN HOLDINGS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →